Is it now the time to update treatment protocols for lymphomas with new anti-virus systems?

Item

http://www.wikidata.org/entity/Q42986624

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Is it now the time to update t ...... s with new anti-virus systems?

@en

Is it now the time to update t ...... s with new anti-virus systems?

@nl

type

Item

label

Is it now the time to update t ...... s with new anti-virus systems?

@en

Is it now the time to update t ...... s with new anti-virus systems?

@nl

prefLabel

Is it now the time to update t ...... s with new anti-virus systems?

@en

Is it now the time to update t ...... s with new anti-virus systems?

@nl

P1476

Is it now the time to update t ...... s with new anti-virus systems?

@en

P2093

Morselli M

http://www.w3.org/2001/XMLSchema#string

Riva G

http://www.w3.org/2001/XMLSchema#string

Torelli G

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.

Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants.

Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.

Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes.

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.

Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.

Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas.

The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.

P2888

sj.leu.2403447

P304

1572-1575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.LEU.2403447

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Leonardo Potenza

Mario Luppi

Patrizia Barozzi

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8424841

http://www.w3.org/2001/XMLSchema#string

P6179

1025658125

http://www.w3.org/2001/XMLSchema#string

P698

15284857

http://www.w3.org/2001/XMLSchema#string